MediWound Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 62.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.7%	Clal Life Sciences L.P.	1,172,710	US$22.2m	0%	no data
8.87%	Point72 Asset Management, L.P.	821,500	US$15.6m	0%	0.03%
5.96%	Israel Biotech Fund	551,255	US$10.4m	35%	28.8%
5.96%	Deep Insight	551,255	US$10.4m	35%	no data
5.25%	Rosalind Advisors, Inc.	485,990	US$9.2m	1.25%	8.0%
3.34%	Clal Biotechnology Industries Ltd.	308,812	US$5.9m	0%	60.39%
2.91%	Lior Rosenberg	269,122	US$5.1m	0%	no data
2.78%	Dafna Capital Management, LLC	257,653	US$4.9m	0%	1.1%
1.76%	Eric Shem-Tov	163,359	US$3.1m	0%	no data
1.57%	Uniplan Investment Counsel, Inc.	145,270	US$2.8m	-3.2%	0.22%
1.43%	Essex Investment Management Company, LLC	132,487	US$2.5m	242%	0.48%
1.43%	Wells Fargo & Company, Securities and Brokerage Investments	132,104	US$2.5m	-3.32%	no data
1.36%	Yelin Lapidot Holdings Ltd.	125,493	US$2.4m	45.7%	0.1%
1.18%	Sargent Investment Group, LLC	109,194	US$2.1m	6.98%	0.43%
1.07%	Ofer Gonen	98,730	US$1.9m	5,230%	no data
1.04%	Sharon Malka	96,127	US$1.8m	0%	no data
0.92%	Silverberg Bernstein Capital Management LLC	85,184	US$1.6m	7.85%	1.68%
0.6%	Renaissance Technologies LLC	55,944	US$1.1m	1.82%	no data
0.53%	Sphera Funds Management Ltd	48,980	US$928.2k	-54.9%	0.14%
0.52%	Legato Capital Management, LLC	47,801	US$905.8k	0%	0.11%
0.34%	Meitav Investment House Ltd	31,502	US$597.0k	0%	0.01%
0.34%	Ronen Zeharia Investment Ltd.	31,502	US$597.0k	0%	0.47%
0.32%	Janney Montgomery Scott LLC, Asset Management Arm	29,948	US$567.5k	0%	no data
0.18%	Citadel Advisors LLC	16,698	US$316.4k	0%	no data
0.16%	Dolphin 1 Investments Ltd.	14,900	US$282.4k	0%	0.49%